Stocktoria

TELEFLEX INC TFX

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1980-03-17 · LEI

TELEFLEX INC financials (annual)

Revenue
$1.87B $2.15B $2.45B $2.60B $2.54B $2.81B $2.79B $1.71B $1.70B $1.99B 2016201720182019202020212022202320242025
Net income
$237.4M $152.5M $200.8M $461.5M $335.3M $485.4M $363.1M $356.3M $69.7M -$905.6M 2016201720182019202020212022202320242025
Free cash flow
$357.5M $355.4M $354.3M $334.4M $346.4M $580.5M $263.6M $159.7M $211.4M $1.4M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.0B$1.7B$1.7B$2.8B$2.8B$2.5B$2.6B$2.4B$2.1B$1.9B
Gross profit$1.1B$1.0B$1.0B$1.5B$1.5B$1.3B$1.4B$1.3B$1.2B$996.2M
R&D expense$144.8M$109.0M$113.6M$153.8M$130.8M$119.7M$113.9M$106.2M$84.8M$58.6M
SG&A expense$720.2M$674.5M$622.7M$863.7M$860.1M$743.6M$851.8M$797.1M$700.0M$563.3M
Operating income$118.4M$103.7M$258.7M$499.7M$628.1M$423.1M$427.3M$321.7M$372.3M$319.5M
Interest expense$85.1M$54.3M$57.0M$66.5M$80.3M$103.0M$82.5M$54.9M
Income tax-$34.0M-$30.9M$41.9M$83.0M$74.3M$21.9M-$122.1M$23.2M$129.6M$8.1M
Net income-$905.6M$69.7M$356.3M$363.1M$485.4M$335.3M$461.5M$200.8M$152.5M$237.4M
EPS (diluted)$-20.25$1.48$7.53$7.68$10.23$7.09$9.80$4.29$3.27$4.98
Operating cash flow$96.7M$301.9M$206.1M$342.8M$652.1M$437.1M$437.1M$435.1M$426.3M$410.6M
Free cash flow$1.4M$211.4M$159.7M$263.6M$580.5M$346.4M$334.4M$354.3M$355.4M$357.5M
Cash & equivalents$378.6M$247.9M$222.8M$292.0M$445.1M$375.9M$301.1M$357.2M$333.6M$543.8M
Inventory$404.4M$306.8M$626.2M$578.5M$477.6M$513.2M$476.6M$427.8M$395.7M$316.2M
Total assets$6.9B$7.1B$7.5B$6.9B$6.9B$7.2B$6.3B$6.3B$6.2B$3.9B
Total liabilities$3.8B$2.8B$3.1B$2.9B$3.1B$3.8B$3.3B$3.7B$3.8B$1.8B
Shareholders' equity$3.1B$4.3B$4.4B$4.0B$3.8B$3.3B$3.0B$2.5B$2.4B$2.1B

Growth · year-over-year · Revenue CAGR 0.7%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+17.2%-0.8%-38.6%-0.7%+10.7%-2.2%+6.0%+14.1%+14.9%+3.2%
Net income growth-1399.8%-80.4%-1.9%-25.2%+44.7%-27.3%+129.8%+31.6%-35.7%-3.1%
EPS growth-1468.2%-80.3%-2.0%-24.9%+44.3%-27.7%+128.4%+31.2%-34.3%-2.4%
Free cash flow growth-99.3%+32.4%-39.4%-54.6%+67.6%+3.6%-5.6%-0.3%-0.6%+47.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.